Literature DB >> 30310497

Hypertension in Chronic Kidney Disease - Role of Arterial Calcification and Impact on Treatment.

Olivier Phan1, Michel Burnier1, Grégoire Wuerzner1,2.   

Abstract

Hypertension contributes to the progression of kidney diseases as well as to the occurrence of cardiovascular events such as myocardial infarction, heart failure and stroke. The prevalence of hypertension is elevated in patients with kidney disease, and increases progressively as glomerular filtration rate falls. A better understanding of the mechanisms leading to hypertension in renal diseases has been gained in recent years; in this article we will review the pathogenesis of hypertension in chronic kidney disease (CKD) with a special focus on vascular calcification because calcification is associated with an increased incidence of cardiovascular morbidity in CKD patients. Although calcification of large arteries and blood pressure increase with age, few studies have specifically investigated a possible connection between these two factors as determinants of the severity of hypertension in CKD. Finally, we will review the trends in hypertension treatment in CKD patients. Expanded understanding of the role of CKD as both a cause and a target of hypertension highlights key points of pathophysiology of hypertension and may contribute to the identification of new strategies for its prevention and treatment.

Entities:  

Keywords:  Hypertension; chronic kidney disease; proteinuria; treatment; vascular calcification

Year:  2014        PMID: 30310497      PMCID: PMC6159424          DOI: 10.15420/ecr.2014.9.2.115

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  55 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

3.  Eligibility for renal denervation: experience at 11 European expert centers.

Authors:  Alexandre Persu; Yu Jin; Marie Baelen; Eva Vink; Willemien L Verloop; Bernhard Schmidt; Marie K Blicher; Francesca Severino; Grégoire Wuerzner; Alison Taylor; Antoinette Pechère-Bertschi; Fadi Jokhaji; Fadl Elmula M Fadl Elmula; Jan Rosa; Danuta Czarnecka; Georg Ehret; Thomas Kahan; Jean Renkin; Jiři Widimsky; Lotte Jacobs; Wilko Spiering; Michel Burnier; Patrick B Mark; Jan Menne; Michael H Olsen; Peter J Blankestijn; Sverre Kjeldsen; Michiel L Bots; Jan A Staessen
Journal:  Hypertension       Date:  2014-03-24       Impact factor: 10.190

4.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

5.  Hemodynamic correlates of proteinuria in chronic kidney disease.

Authors:  Matthew R Weir; Raymond R Townsend; Jeffrey C Fink; Valerie Teal; Cheryl Anderson; Lawrence Appel; Jing Chen; Jiang He; Natasha Litbarg; Akinlolu Ojo; Mahboob Rahman; Leigh Rosen; Stephen M Sozio; Susan Steigerwalt; Louise Strauss; Marshall M Joffe
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

6.  Mineral metabolites and CKD progression in African Americans.

Authors:  Julia J Scialla; Brad C Astor; Tamara Isakova; Huiliang Xie; Lawrence J Appel; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 10.121

7.  Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat.

Authors:  Paul A Price; Matthew K Williamson; Thao Minh Thi Nguyen; Truclinh N Than
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

8.  Telmisartan to prevent recurrent stroke and cardiovascular events.

Authors:  Salim Yusuf; Hans-Christoph Diener; Ralph L Sacco; Daniel Cotton; Stephanie Ounpuu; William A Lawton; Yuko Palesch; Reneé H Martin; Gregory W Albers; Philip Bath; Natan Bornstein; Bernard P L Chan; Sien-Tsong Chen; Luis Cunha; Björn Dahlöf; Jacques De Keyser; Geoffrey A Donnan; Conrado Estol; Philip Gorelick; Vivian Gu; Karin Hermansson; Lutz Hilbrich; Markku Kaste; Chuanzhen Lu; Thomas Machnig; Prem Pais; Robin Roberts; Veronika Skvortsova; Philip Teal; Danilo Toni; Cam VanderMaelen; Thor Voigt; Michael Weber; Byung-Woo Yoon
Journal:  N Engl J Med       Date:  2008-08-27       Impact factor: 91.245

Review 9.  Thiazide diuretics in advanced chronic kidney disease.

Authors:  Rajiv Agarwal; Arjun D Sinha
Journal:  J Am Soc Hypertens       Date:  2012-08-28

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  5 in total

1.  Sonographic assessment of kidneys in patients with hypertension co-existed with diabetes mellitus and ischemic heart disease.

Authors:  Moawia Gameraddin; Walaa Ismail Musa; Suzan Abdelmaboud; Sultan Alshoabi; Kamal Dahan Alsultan; Bushra A Abdelmalik
Journal:  J Family Med Prim Care       Date:  2020-05-31

2.  Prevalence and characterization of undiagnosed arterial hypertension in the eastern zone of Mexico.

Authors:  Silvia Palomo-Piñón; Neftali Eduardo Antonio-Villa; Luis Rey García-Cortés; Cleto Álvarez-Aguilar; Esteban González-Palomo; Olga Margarita Bertadillo-Mendoza; María Eugenia Figueroa-Suárez; Francisco Vargas-Hernández; Imer Guillermo Herrera-Olvera; Jairo Enoc Cruz-Toledo; Maria Adriana Cruz-Arce; Berenice Serafín-Méndez; Gerardo Muñoz-Cortés; Claudia Janeth Morfin-Macias
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-28       Impact factor: 3.738

3.  Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial.

Authors:  Fabio Solis-Jimenez; Lucia Monserrat Perez-Navarro; Ricardo Cabrera-Barron; Jesus Antonio Chida-Romero; Geovana Martin-Alemañy; Edgar Dehesa-López; Magdalena Madero; Rafael Valdez-Ortiz
Journal:  BMC Nephrol       Date:  2022-09-20       Impact factor: 2.585

4.  Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer.

Authors:  Jonathan Slawik; Juliane Dederer; Ingrid Kindermann; Michael Böhm
Journal:  ESC Heart Fail       Date:  2020-06-17

5.  Polypharmacy in the Management of Arterial Hypertension-Friend or Foe?

Authors:  Camelia Cristina Diaconu; Matei-Alexandru Cozma; Elena-Codruța Dobrică; Gina Gheorghe; Alexandra Jichitu; Vlad Alexandru Ionescu; Alina Crenguța Nicolae; Cristina Manuela Drăgoi; Mihnea-Alexandru Găman
Journal:  Medicina (Kaunas)       Date:  2021-11-23       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.